Search Within

Mario E Lacouture

Formats
  1. Journal Article (220)
  2. Meeting Abstract (171)
  3. Book Section (25)
  4. Review (18)
  5. Research Letter (9)
  6. Guidelines (5)
  7. Book Whole (2)
  8. Conference Paper (2)
  9. Editorial (2)
  10. Miscellaneous (2)
  11. Correspondence (1)
Groups
  1. Department of Medicine (457)
  2. Dermatology (457)
  3. Dermatology Service (457)
  4. Division of Subspecialty Medicine (457)
  5. Survivorship Research (457)
  6. Solid Tumor Oncology Division (142)

More Groups

People
  1. Viswanath Reddy Belum (37)
  2. Shari Goldfarb (34)
  3. Alina Markova (31)
  4. Azael Freites Martinez (27)
  5. Yevgeniy Balagula (26)
  6. Stephen Dusza (25)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (24)
  4. 2022 (31)
  5. 2021 (32)
  6. 2020 (27)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Journal of the American Academy of Dermatology (51)
  3. Annals of Oncology (20)
  4. Supportive Care in Cancer (17)
  5. The Oncologist (16)
  6. Blood (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (92)
  2. Mosby Elsevier (55)
  3. Oxford University Press (44)
  4. Elsevier Inc. (35)
  5. Springer (34)
  6. Wiley Blackwell (29)

More Publishers

Results (457)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histopathologic and immunohistochemical findings of skin rash to HER1 and HER1/2 inhibitors during anticancer therapy
    Meeting Abstract

    Nardone, B.; Kaklamani, V. G.; Nicholson, K. M.; Newman, M.; Guitart, J.; Gerami, P.; Talarico, N.; Rademarker, A.; West, D. P.; Lacouture, M. E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • PLX4032 (RG7204), a selective mutant RAF inhibitor: Clinical and histologic characteristics of therapy-associated cutaneous neoplasms in a phase I trial
    Meeting Abstract

    Lacouture, M. E.; McArthur, G. A.; Chapman, P. B.; Ribas, A.; Flaherty, K. T.; Lee, R. J.; Nolop, K. B.; Kim, K. B.; Duvic, M.; Sosman, J. A.; more...
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash with cetuximab in cancer patients: A meta-analysis
    Meeting Abstract

    Balagula, Y.; Wu, S.; Su, X.; Dusza, S. W.; Lacouture, M. E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-emptive skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer
    Journal Article

    Lacouture, M. E.; Mitchell, E. P.; Piperdi, B.; Pillai, M. V.; Shearer, H.; Iannotti, N.; Xu, F.; Yassine, M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Practical considerations in the management of hand-foot skin reaction caused by multikinase inhibitors
    Journal Article

    Wood, L. S.; Lemont, H.; Jatoi, A.; Lacouture, M. E.; Robert, C.; Keating, K.; Anderson, R.
    Community Oncology (2010)

    Fulltext@MSK | Save
  • A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group
    Journal Article

    Lacouture, M. E.; Maitland, M. L.; Segaert, S.; Setser, A.; Baran, R.; Fox, L. P.; Epstein, J. B.; Barasch, A.; Einhorn, L.; Wagner, L.; more...
    Supportive Care in Cancer (2010)

    Fulltext@MSK | Save
  • Acneiform rash as a reaction to radiotherapy in a breast cancer patient
    Journal Article

    Balagula, Y.; Hensley, J. R.; Gerami, P.; Lacouture, M. E.
    The Journal of Supportive Oncology (2010)

    Fulltext@MSK | Save